Diligence memo · auto-generated · as of July 2, 2026
Ascribe Bioscience Inc.
Ascribe Bioscience Inc. looks fair against its niche peers and is active on financing cadence.
Businessfiled
Ascribe Bioscience Inc. operates in Agriculture, based in ITHACA.
Sub-sector tags: biotech.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Ascribe Bioscience Inc. has raised $23M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $15M on 2025-10-08.
Most recent recorded round closed around 2025-10-08.
Valuation (modeled)modeled
Provath models Ascribe Bioscience Inc. at approximately $61M (range $36M–$85M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.00× the median modeled value of Series B Agriculture companies in 2025–2027 (9 peers) — value vs value, same stage and era. Within the normal band (100% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 16 months.
Last raise 9 mo ago; this sector typically re-raises about every 11 months.
Raising on or ahead of the sector's normal rhythm.
The last round stepped up 7.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 89% of Agriculture peers (1055 compared).
Modeled value ranks above 84% of those peers.
Closest niche peers: California Reserve Flower, LLC, Select Milk Producers, Inc., Local Bounti Corporation/DE, VM Agritech Inc., M.N. Technology LLC.
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.